- 米国企業
- AGIOS PHARMACEUTICALS, INC.
AGIOS PHARMACEUTICALS, INC.AGIO
| 2013年
12月31日 | 2014年
12月31日 | 2015年
12月31日 | 2016年
12月31日 | 2017年
12月31日 | 2018年
12月31日 | 2019年
12月31日 | 2020年
12月31日 | 2021年
12月31日 | 2022年
12月31日 | 2023年
12月31日 |
|---|
| Product | - | - | - | - | - | 14 | 60 | 121 | - | 12 | 27 |
|---|
| Royalty | - | - | - | - | - | 7 | 11 | 10 | - | 3 | - |
|---|
| Total revenue | 26 | 65 | - | - | 43 | 94 | 118 | 203 | - | 14 | 27 |
|---|
| Product | - | - | - | - | - | 14 | 60 | 121 | - | 12 | 27 |
|---|
| Royalty | - | - | - | - | - | 7 | 11 | 10 | - | 3 | - |
|---|
| Total revenue | 26 | 65 | - | - | 43 | 94 | 118 | 203 | - | 14 | 27 |
|---|
| Cost of sales | - | - | - | - | - | 1 | 1 | 3 | - | 2 | 3 |
|---|
| Research and development | 55 | 100 | 142 | 220 | 293 | 341 | 411 | 367 | 257 | 280 | 296 |
|---|
| Selling, general and administrative | - | - | - | - | - | 114 | 132 | 149 | 121 | 122 | 120 |
|---|
| Total operating expenses | - | - | - | - | - | - | 544 | 519 | 378 | 403 | 418 |
|---|
| Loss from operations | -39 | -54 | -119 | -201 | -321 | -362 | -426 | -316 | -378 | -389 | -391 |
|---|
| Gain on sale of contingent payments | - | - | - | - | - | - | - | - | - | 128 | - |
|---|
| Royalty Income, Nonoperating | - | - | - | - | - | - | - | - | - | 10 | - |
|---|
| Interest income, net | 0 | 0 | 1 | 3 | 6 | 16 | 15 | 7 | 1 | 13 | - |
|---|
| Interest income, net | - | - | - | - | - | - | - | - | - | - | 33 |
|---|
| Other income, net | - | - | - | - | - | - | - | - | 14 | 7 | 6 |
|---|
| Net loss from continuing operations | -39 | -54 | -118 | -198 | - | - | - | - | -357 | -232 | -352 |
|---|
| Net income from discontinued operations, net of tax | - | - | - | - | - | - | - | - | 1,961 | - | - |
|---|
| Net (loss) income | -39 | -54 | -118 | -198 | -315 | -346 | -411 | -327 | 1,605 | -232 | -352 |
|---|
| Income (Loss) from Continuing Operations, Per Basic Share | - | - | - | - | - | - | - | - | -5.9 | -4.23 | -6.33 |
|---|
| Income (Loss) from Continuing Operations, Per Diluted Share | - | - | - | - | - | - | - | - | -5.9 | -4.23 | -6.33 |
|---|
| Net income from discontinued operations per share - basic (in usd per share) | - | - | - | - | - | - | - | - | 32.45 | - | - |
|---|
| Net income from discontinued operations per share - diluted (in usd per share) | - | - | - | - | - | - | - | - | 32.45 | - | - |
|---|
| Earnings Per Share, Basic | - | - | - | - | - | - | - | - | 26.55 | -4.23 | -6.33 |
|---|
| Earnings Per Share, Diluted | - | - | - | - | - | - | - | - | 26.55 | -4.23 | -6.33 |
|---|